| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |